Coon, Elizabeth A. https://orcid.org/0000-0003-1206-0222
Golden, Elisabeth P.
Bryarly, Meredith
McGregor, Tamara
Nguyen, Benjamin N.
Moutvic, Margaret A.
Cutsforth-Gregory, Jeremy K.
Stevens, Patricia M.
Chou, Claudia Z.
Rhee, Laura
Vernino, Steven
Funding for this research was provided by:
Rex Griswold Foundation
CTSA (UL1 TR002377)
Article History
Received: 18 February 2022
Accepted: 20 April 2022
First Online: 12 May 2022
Declarations
:
: On behalf of all authors, the corresponding author states that there is no conflict of interest. EA Coon has no disclosures. EP Golden has been funded by the Ware Group. M Bryarly has no disclosures. T McGregor has no disclosures. B Nguyen has no disclosures. M Moutvic has no disclosures. JK Cutsforth-Gregory has no disclosures. PM Stevens has no disclosures. CZ Chou has no disclosures. L Rhee has no disclosures. S Vernino has served as a consultant for Alterity, Argenx, Catalyst, LabCorp, and Sage Therapeutics.
: The authors confirm that the approval of an institutional review board was not required for this work. Informed consent was obtained. We confirm that we have read the Journal’s position on issues involved in ethical publication and affirm that his work is consistent with those guidelines.